Catechol O-methyltransferase
From Proteopedia
(Difference between revisions)
| Line 37: | Line 37: | ||
**[[2avd]] – hCOMT + SAM – human <BR /> | **[[2avd]] – hCOMT + SAM – human <BR /> | ||
**[[3bwm]], [[3a7e]] – hCOMT + SAM + dinitrocatechol <BR /> | **[[3bwm]], [[3a7e]] – hCOMT + SAM + dinitrocatechol <BR /> | ||
| - | **[[3bwy]] – hCOMT (mutant) + SAM + dinitrocatechol <BR /> | + | **[[3bwy]], [[4xuc]] – hCOMT (mutant) + SAM + dinitrocatechol <BR /> |
**[[4p58]] – mCOMT + inhibitor <BR /> | **[[4p58]] – mCOMT + inhibitor <BR /> | ||
}} | }} | ||
Revision as of 10:32, 28 March 2017
| |||||||||||
3D Structures of catechol O-methyltransferase
Updated on 28-March-2017
References
- ↑ Tsuji E, Okazaki K, Isaji M, Takeda K. Crystal structures of the Apo and Holo form of rat catechol-O-methyltransferase. J Struct Biol. 2008 Dec 10. PMID:19111934 doi:S1047-8477(08)00293-1
- ↑ Muller T. Catechol-O-methyltransferase inhibitors in Parkinson's disease. Drugs. 2015 Feb;75(2):157-74. doi: 10.1007/s40265-014-0343-0. PMID:25559423 doi:http://dx.doi.org/10.1007/s40265-014-0343-0
